Health
When Algorithms Meet Electrodes Inside the Brain
Artificial intelligence is quietly revolutionizing electroconvulsive therapy, promising smarter, safer treatment for depression and psychosis.
Artificial intelligence is quietly revolutionizing electroconvulsive therapy, promising smarter, safer treatment for depression and psychosis.
OptiTROP-Lung03 trial shows sacituzumab tirumotecan nearly triples progression-free survival in pretreated EGFR-mutant NSCLC
Zongertinib's Beamion LUNG-1 trial delivers breakthrough results for HER2-mutant NSCLC, including remarkable brain metastasis control
Setidegrasib targets KRAS G12D — a notoriously elusive oncogene — and early results are rewriting what's possible in lung and pancreatic cancer.
How genomic medicine is transforming personalized care, disease prevention, and the future of treatment planning